Geopolitical tensions are escalating to levels not seen in decades, global trade relationships face unprecedented strain, and ...

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

Budgeted spending for NIH BRAIN Initiative has plunged by more than half, from $680 million in 2023 to $320 million this year ...

Medtronic Evolut TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients: Galway, Ireland Tuesday, April 1 ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological ...

To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...

Shares of Medtronic PLC MDT rallied 2.54% to $89.86 Monday, on what proved to be an all-around great trading session for the ...

The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of ...

Medtronic (NYSE:MDT) recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by ...

Today's Research Daily features new research reports on 12 major stocks, including Mastercard Incorporated (MA), Medtronic ...